
T2 Biosystems TTOO
Quarterly report 2024-Q3
added 05-16-2026
T2 Biosystems P/CF Ratio 2011-2026 | TTOO
Annual P/CF Ratio T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.162 | -0.000494 | -0.0343 | -5.59 | -0.893 | -3.54 | -3.33 | -3.02 | -4.85 | -6.2 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.000494 | -6.2 | -2.76 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 204.95 | 0.21 % | $ 22.7 B | ||
|
Celcuity
CELC
|
-35 | $ 87.79 | -5.18 % | $ 4.1 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
-5.18 | $ 18.93 | 2.35 % | $ 583 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 4.22 | -6.33 % | $ 5.61 M | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 21.07 | -0.05 % | $ 611 M | ||
|
Aspira Women's Health
AWH
|
-0.0975 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.0826 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-72.7 | $ 131.33 | 0.93 % | $ 16.5 B | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 22.97 | 0.95 % | $ 1.22 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
9.76 | $ 150.63 | -0.78 % | $ 11.8 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Illumina
ILMN
|
23.4 | $ 164.44 | 2.76 % | $ 25.5 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.79 | 2.87 % | $ 7.92 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
0.495 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-23.5 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.877 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 102.1 | 2.12 % | $ 6.89 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 190.0 | 0.08 % | $ 9.42 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 473.68 | 1.47 % | $ 13.7 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
29.7 | $ 1 136.75 | -2.26 % | $ 23.4 B | ||
|
NeoGenomics
NEO
|
284 | $ 11.69 | 2.19 % | $ 1.5 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.61 | 1.54 % | $ 427 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 20.0 | 1.27 % | $ 448 M | ||
|
Natera
NTRA
|
142 | $ 218.15 | -2.1 % | $ 29.8 B | ||
|
Pacific Biosciences of California
PACB
|
-4.48 | $ 1.37 | -0.36 % | $ 411 M | ||
|
Personalis
PSNL
|
-5.75 | $ 9.71 | -0.41 % | $ 867 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 25.9 | -2.26 % | $ 24.6 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 7.17 | -3.45 % | $ 299 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 68.23 | -2.61 % | $ 4.08 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 272.64 | 0.53 % | $ 22.7 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 486.81 | -1.47 % | $ 184 B | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.67 | 1.61 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
30.1 | $ 368.54 | -0.7 % | $ 21.9 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.24 | -0.48 % | $ 2 B |